Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Histological biopsy procedure
PROCEDURE
2 trials
Sponsors
Foundation CPCT
, P.O. Witteveen
Conditions
Metastatic Disease
Solid Tumors
Unknown Phase
CPCT-02 Biopsy Protocol
Completed
NCT01855477
Foundation CPCT
Metastatic Disease, Solid Tumors
Start: 2011-08-17
End: 2023-12-18
Updated: 2024-07-19
CPCT-05 Biopsy Protocol Patient Selection
Terminated
NCT01904916
P.O. Witteveen
Metastatic Disease, Solid Tumors
Start: 2014-01-31
End: 2017-03-31
Updated: 2018-03-09
Related Papers
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications.
2025-03-20
The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP).
2025-01-07
3 citations
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling
Cancers
2023-09-04
6 citations
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.
2023-07-03
2 citations
mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor.
Journal of Clinical Oncology
2023-06-01
2 citations
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors
Biomedicine & Pharmacotherapy
2023-01-06
4 citations
Abstract B066: Elucidating the role of insulin receptor isoform expression in metastatic pancreatic ductal adenocarcinoma
Cancer Research
2022-11-15
1 citations
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study
BMC Medical Genomics
2022-11-04
6 citations
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
2022-01-25
36 citations
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features
Nature Communications
2021-01-25
77 citations
Abstract 5673: In-depth analysis of the genomic landscape of 91 metastatic neuroendocrine tumors reveals subtype-heterogeneity and potential therapeutic targets
Cancer Research
2020-08-15
<sup>68</sup>Ga-PSMA–Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer
Journal of Nuclear Medicine
2020-03-13
19 citations
Abstract GS1-07: The genomic landscape of 501 metastatic breast cancer patients
Cancer Research
2019-02-15
3 citations